AUSTIN, Texas, April 29, 2025 /PRNewswire/ -- AlphaRose Therapeutics, an advanced preclinical-stage biotechnology company focused on developing and commercializing therapeutics for neurogenetic ...
A new sensor probes a well-known, but poorly understood, effect in carbohydrate chemistry that controls the conformations of many biologically relevant sugars. The work provides experimental evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback